Annual report pursuant to Section 13 and 15(d)

Shareholders' Equity (Details) - Schedule of stock options activity

v3.22.1
Shareholders' Equity (Details) - Schedule of stock options activity - Warrant [Member] - $ / shares
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Shareholders' Equity (Details) - Schedule of stock options activity [Line Items]    
Options Outstanding, Balance (in Shares) 2,668,866 1,661,466
Weighted Average Exercise Price, Balance $ 2.48 $ 3.38
Weighted Average Fair Value at Issue, Balance $ 1.13 $ 2.38
Options Outstanding, Issued (in Shares) 1,132,000 1,255,000
Weighted Average Exercise Price, Issued $ 2.47 $ 1.44
Weighted Average Fair Value at Issue, Issued $ 2.37 $ 1.13
Options Outstanding ,Exercised (in Shares) (215,556)  
Weighted Average Exercise Price, Exercised $ 2.18  
Weighted Average Fair Value at Issue,Exercised $ 0.89  
Options Outstanding, Cancelled (in Shares)   (247,600)
Weighted Average Exercise Price, Cancelled   $ 3.27
Weighted Average Fair Value at Issue, Cancelled   $ 2.04
Options Outstanding, Balance (in Shares) 3,585,310 2,668,866
Weighted Average Remaining Term (Years) , Balance 7 years 9 months 18 days 8 years 1 month 2 days
Weighted Average Exercise Price, Balance $ 2.64 $ 2.48
Weighted Average Fair Value at Issue , Balance $ 2.02 $ 1.13
Options Outstanding,Outstanding, vested and exercisable (in Shares) 2,172,922  
Weighted Average Remaining Term (Years),Outstanding, vested and exercisable 7 years 4 months 24 days  
Weighted Average Exercise Price,Outstanding, vested and exercisable $ 2.78  
Weighted Average Fair Value at Issue ,Outstanding, vested and exercisable $ 2.08